AbbVie Inc's Fiscal Year is From January To December.
The item "Financial-Leverage-Ratio" stands at 282.50 as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.
As of the end of AbbVie Inc's third quarter, the item "Financial Leverage Ratio" stands at 282.50. This represents an increase of 442.25 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 1,448.06 percent compared to the value the year prior.
The 1 year change in percent is 1,448.06.
The 3 year change in percent is 2,966.72.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Financial Leverage Ratio | 905,699,262,464.00 |
![]() | Johnson & Johnson - Financial Leverage Ratio | 486,508,953,600.00 |
![]() | Roche Holding AG - Financial Leverage Ratio | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Financial Leverage Ratio | 280,205,508,085.11 |
![]() | Novartis AG - Financial Leverage Ratio | 255,096,620,580.91 |